Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use - Full Text View

Sponsors and Collaborators:	Norwegian University of Science and Technology St. Olavs Hospital
Information provided by:	Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:	NCT00184223

Purpose

The purpose for this study is to determine whether 2x45 minutes Motivational Interviewing given during hospital stay to acutely admitted psychiatric patients with substance use problems, can reduce substance use after discharge.

Condition	Intervention	Phase
Substance-Related Disorders Emergency Services, Psychiatric	Behavioral: Motivational Interviewing	Phase II

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:

Substance use and function questionnaire
Admissions to hospital
Number of contacts with primary ealth care

Secondary Outcome Measures:

Substance use and function questionnaire
Admissions to hospital
Number of contacts with primary ealth care

Estimated Enrollment:	135
Study Start Date:	October 2004
Estimated Study Completion Date:	June 2005

Detailed Description:

The aims of the study are in a randomized controlled trial to compare the effects of 2 x 45 minutes Motivational Interviewing and standard treatment with standard treatment alone.All patients acutely admitted to Østmarka Psychiatric Hospital are evaluated for substance use, and all patients with substance use that give their consent to participate are randomized to Motivational Interviewing and standard treatment or standard treatment alone.

Substance use and function will be followed for two years.Admittances to hospital and contacts with primary health care for five years.

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria: adult patients with substance use acutely admitted to psychiatric hospital -

Exclusion Criteria: dementia, serious brain damage,do not speak Norwegian nor English language

-

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00184223

Locations

Norway
Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim
Trondheim, Norway

Sponsors and Collaborators

Norwegian University of Science and Technology

St. Olavs Hospital

Investigators

Principal Investigator:

Gunnar Morken, MD PhD

Norwegian University of Science and Technology

More Information

Study ID Numbers:	GB-MI-2004
Study First Received:	September 13, 2005
Last Updated:	July 24, 2006
ClinicalTrials.gov Identifier:	NCT00184223
Health Authority:	Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:

Motivational Interviewing
Substance abuse
Acuteley admitted psychiatric patients

Study placed in the following topic categories:

Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin
Emergencies

Additional relevant MeSH terms:

Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on January 14, 2009